DBV Technologies to Participate in Upcoming Investor Conferences
November 09 2020 - 12:30AM
Montrouge, France, November 9, 2020DBV
Technologies to Participate in Upcoming Investor
Conferences
DBV Technologies (Euronext: DBV – ISIN:
FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage
biopharmaceutical company, today announced its participation in the
following virtual investor conferences. At each conference, Daniel
Tassé, Chief Executive Officer, will participate in a fireside
chat.
Credit Suisse Healthcare
Conference, November
9-12.The fireside chat will take place on
Wednesday, November 11, 2020 at 12:30PM ET.
Stifel Healthcare Conference, November
16. The fireside chat will take place on
Monday, November 16, 2020 at 8AM ET.
Evercore HealthconX, December
1-3.The fireside chat will take place on
Tuesday, December 1, 2020 at 12:35PM ET.
A live webcast of the fireside chats will be
available on the Investors & Media section of the Company’s
website: https://www.dbv-technologies.com/investor-relations/
A replay of the presentations will also be
available on DBV’s website after the event.
About DBV TechnologiesDBV
Technologies is developing Viaskin™, an investigational proprietary
technology platform with broad potential applications in
immunotherapy. Viaskin™ is based on epicutaneous immunotherapy, or
EPIT™, DBV’s method of delivering biologically active compounds to
the immune system through intact skin. With this new class of
non-invasive product candidates, the Company is dedicated to safely
transforming the care of food allergic patients. DBV’s food
allergies programs include ongoing clinical trials of Viaskin™
Peanut. DBV Technologies has global headquarters in Montrouge,
France and offices in Bagneux, France, and North American
operations in Summit, NJ and New York, NY. The Company’s ordinary
shares are traded on segment B of Euronext Paris (Ticker: DBV, ISIN
code: FR0010417345), part of the SBF120 index, and the Company’s
ADSs (each representing one-half of one ordinary share) are traded
on the Nasdaq Global Select Market (Ticker: DBVT).
Investor Relations ContactAnne
Pollak+ 1 (857) 529-2363anne.pollak@dbv-technologies.com
Media ContactAngela Marcucci+ 1
(646) 842-2393angela.marcucci@dbv-technologies.com
DBV Technologies (NASDAQ:DBVT)
Historical Stock Chart
From Apr 2024 to May 2024
DBV Technologies (NASDAQ:DBVT)
Historical Stock Chart
From May 2023 to May 2024